EMA Authorised: Feraccru (ferric maltol) — Norgine B.V.

View source ↗

Summary

Feraccru (ferric maltol) has been authorised in the EU for iron deficiency anemia, expanding options for treatment of iron-deficiency anemia. Decision date 15/1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Feraccru (ferric maltol)

Snippet

Status: Authorised. Therapeutic area: Anemia, Iron-Deficiency. MAH: Norgine B.V.. Decision date: 15/12/2023